FERMENTA BIOTECH
|
FERMENTA BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -7.99 | -17.70 | 5.35 | 15.77 | 20.63 |
| CEPS(Rs) | 0.25 | -8.62 | 14.08 | 21.78 | 25.83 |
| DPS(Rs) | 1.25 | 1.25 | 1.25 | 2.50 | 5.00 |
| Book NAV/Share(Rs) | 95.63 | 104.67 | 123.91 | 120.84 | 105.16 |
| Tax Rate(%) | -143.18 | -3.56 | 44.10 | 17.63 | -37.08 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 8.31 | 5.20 | 15.62 | 21.89 | 21.95 |
| EBIT Margin(%) | 2.25 | -8.55 | 11.27 | 18.72 | 21.68 |
| Pre Tax Margin(%) | -2.94 | -14.66 | 6.76 | 13.68 | 14.82 |
| PAT Margin (%) | -7.15 | -15.18 | 3.78 | 11.27 | 20.32 |
| Cash Profit Margin (%) | 0.21 | -7.11 | 10.19 | 16.66 | 25.44 |
| Performance Ratios | |||||
| ROA(%) | -4.01 | -7.63 | 2.04 | 6.56 | 10.75 |
| ROE(%) | -8.30 | -16.11 | 4.27 | 13.05 | 21.92 |
| ROCE(%) | 1.58 | -5.25 | 7.50 | 12.62 | 12.98 |
| Asset Turnover(x) | 0.56 | 0.50 | 0.54 | 0.58 | 0.53 |
| Sales/Fixed Asset(x) | 0.93 | 1.08 | 1.25 | 1.52 | 1.98 |
| Working Capital/Sales(x) | 4.90 | 7.90 | 3.73 | 3.76 | 3.28 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.08 | 0.93 | 0.80 | 0.66 | 0.50 |
| Receivable days | 60.61 | 67.14 | 71.03 | 66.65 | 84.30 |
| Inventory Days | 118.27 | 151.04 | 147.34 | 140.69 | 134.72 |
| Payable days | 155.24 | 131.18 | 150.99 | 160.90 | 228.76 |
| Valuation Parameters | |||||
| PER(x) | - | - | 38.41 | 15.87 | 10.31 |
| PCE(x) | 615.28 | -12.40 | 14.61 | 11.49 | 8.24 |
| Price/Book(x) | 1.58 | 1.02 | 1.66 | 2.07 | 2.02 |
| Yield(%) | 0.83 | 1.17 | 0.61 | 1.00 | 2.35 |
| EV/Net Sales(x) | 1.52 | 1.33 | 2.00 | 2.40 | 2.73 |
| EV/Core EBITDA(x) | 12.84 | 17.44 | 11.29 | 9.97 | 10.20 |
| EV/EBIT(x) | 67.47 | -15.61 | 17.72 | 12.84 | 12.61 |
| EV/CE(x) | 1.21 | 0.88 | 1.06 | 1.26 | 1.39 |
| M Cap / Sales | 1.30 | 0.88 | 1.49 | 1.91 | 2.09 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -4.08 | -12.19 | 5.63 | 28.79 | -27.61 |
| Core EBITDA Growth(%) | 48.17 | -61.99 | -22.50 | 15.84 | -51.48 |
| EBIT Growth(%) | 125.23 | -166.63 | -36.40 | 11.22 | -57.64 |
| PAT Growth(%) | 54.81 | -452.79 | -64.59 | -28.54 | -49.52 |
| EPS Growth(%) | 54.88 | -430.53 | -66.06 | -23.55 | -83.88 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.48 | 0.72 | 0.66 | 0.66 | 0.73 |
| Current Ratio(x) | 1.35 | 1.19 | 1.47 | 1.44 | 1.46 |
| Quick Ratio(x) | 0.90 | 0.63 | 0.77 | 0.73 | 0.80 |
| Interest Cover(x) | 0.43 | -1.40 | 2.50 | 3.72 | 3.16 |
| Total Debt/Mcap(x) | 0.30 | 0.69 | 0.39 | 0.31 | 0.35 |
Compare Financial Ratios of peers of FERMENTA BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FERMENTA BIOTECH | ₹780.3 Cr | -2.5% | -7% | 53.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,379.0 Cr | 0.8% | 7.2% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,420.0 Cr | 0.7% | 11% | 53.3% | Stock Analytics | |
| CIPLA | ₹122,010.0 Cr | -2% | 4.6% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹110,634.0 Cr | -1.6% | 2.8% | 24.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,788.5 Cr | -1.4% | 0.7% | -5.5% | Stock Analytics | |
FERMENTA BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | -2.5% |
-7% |
53.1% |
| SENSEX | 0.5% |
4.2% |
8% |
You may also like the below Video Courses
